Literature DB >> 10859376

Antigenic properties of human parechovirus 1.

P Joki-Korpela1, M Roivainen, H Lankinen, T Pöyry, T Hyypiä.   

Abstract

Human parechoviruses 1 and 2 (HPEV1 and HPEV2, respectively), formerly known as echoviruses 22 and 23, have been assigned to a novel picornavirus genus on the basis of their distinct molecular and biological properties. To study the immunological characteristics of HPEV1 capsid proteins, antigenic analysis was carried out by a peptide scanning technique, which can be used to identify the immunogenic peptide sequences of a protein. Partially overlapping peptides, representing the capsid of HPEV1, were synthesized using a 12 aa window in a three residue shift and reactivity of rabbit and murine HPEV1 antisera against these peptides were tested. Using this method, an antigenic site in the VP0 polypeptide, recognized by both rabbit and murine antisera, was identified. The sequence of this region was conserved among HPEV1 clinical isolates obtained from Finland and the United States. Antiserum against this peptide region showed neutralizing activity against HPEV1 in cell culture. Because the C-terminal region of HPEV1 VP1 contains a functional RGD motif, the antigenicity of this region was also tested. By using the corresponding peptide antiserum, neutralization of HPEV1 was observed. Cross-neutralization between HPEV1 and coxsackievirus A9, an enterovirus with a similar RGD motif in VP1, was also detected.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10859376     DOI: 10.1099/0022-1317-81-7-1709

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  26 in total

1.  Arginine-glycine-aspartic acid motif is critical for human parechovirus 1 entry.

Authors:  Y Boonyakiat; P J Hughes; F Ghazi; G Stanway
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

2.  A member of a new Picornaviridae genus is shed in pig feces.

Authors:  Virginie Sauvage; Meriadeg Ar Gouilh; Justine Cheval; Erika Muth; Kevin Pariente; Ana Burguiere; Valérie Caro; Jean-Claude Manuguerra; Marc Eloit
Journal:  J Virol       Date:  2012-07-11       Impact factor: 5.103

3.  Analysis of a new human parechovirus allows the definition of parechovirus types and the identification of RNA structural domains.

Authors:  Mohammed Al-Sunaidi; Cigdem H Williams; Pamela J Hughes; David P Schnurr; Glyn Stanway
Journal:  J Virol       Date:  2006-09-27       Impact factor: 5.103

Review 4.  Human Parechovirus: an Increasingly Recognized Cause of Sepsis-Like Illness in Young Infants.

Authors:  Laudi Olijve; Lance Jennings; Tony Walls
Journal:  Clin Microbiol Rev       Date:  2017-11-15       Impact factor: 26.132

5.  Entry of human parechovirus 1.

Authors:  P Joki-Korpela; V Marjomäki; C Krogerus; J Heino; T Hyypiä
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

6.  Human Memory B Cells Producing Potent Cross-Neutralizing Antibodies against Human Parechovirus: Implications for Prevalence, Treatment, and Diagnosis.

Authors:  B M Westerhuis; K S M Benschop; G Koen; Y B Claassen; K Wagner; A Q Bakker; K C Wolthers; T Beaumont
Journal:  J Virol       Date:  2015-05-06       Impact factor: 5.103

7.  Molecular analysis of three Ljungan virus isolates reveals a new, close-to-root lineage of the Picornaviridae with a cluster of two unrelated 2A proteins.

Authors:  Susanne Johansson; Bo Niklasson; Jacob Maizel; Alexander E Gorbalenya; A Michael Lindberg
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

8.  Structural Basis of Human Parechovirus Neutralization by Human Monoclonal Antibodies.

Authors:  Shabih Shakeel; Brenda M Westerhuis; Ari Ora; Gerrit Koen; Arjen Q Bakker; Yvonne Claassen; Koen Wagner; Tim Beaumont; Katja C Wolthers; Sarah J Butcher
Journal:  J Virol       Date:  2015-07-08       Impact factor: 5.103

9.  EBV-positive human sera contain antibodies against the EBV BMRF-2 protein.

Authors:  Jianqiao Xiao; Joel M Palefsky; Rossana Herrera; Carl Sunshine; Sharof M Tugizov
Journal:  Virology       Date:  2009-08-20       Impact factor: 3.616

10.  Prevalence of human parechovirus in the Netherlands in 2000 to 2007.

Authors:  Sabine van der Sanden; Erwin de Bruin; Harry Vennema; Caroline Swanink; Marion Koopmans; Harrie van der Avoort
Journal:  J Clin Microbiol       Date:  2008-07-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.